Ruth Plummer
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 2%
Papers in
- Oncology 121
- PARP inhibition in cancer therapy 42
- Cancer Immunotherapy and Biomarkers 24
- Colorectal Cancer Treatments and Studies 18
- Cancer Treatment and Pharmacology 9
-
- DNA Repair Mechanisms 24
- Melanoma and MAPK Pathways 21
- Co-authors
- Hilary Calvert (22 shared papers)Alan V. Boddy (10 shared papers)Timothy Anthony Yap (10 shared papers)Mark Ross Middleton (15 shared papers)Yvette Drew (13 shared papers)Richard H. Wilson (12 shared papers)Nicola J. Curtin (12 shared papers)Johann Sebastian De Bono (19 shared papers)
- Journals
- Annals of Oncology (42 papers)British Journal of Cancer (23 papers)Clinical Cancer Research (19 papers)European Journal of Cancer (16 papers)Cancer Chemotherapy and Pharmacology (8 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Ruth Plummer
221 papers receiving 10.9k citations
Ruth Plummer's Hit Papers
Peers
Comparison fields: 5 of 134
- Oncology 5.3k
- Cancer Research 1.1k
- Molecular Biology 5.1k
- Immunology 1.1k
- Pulmonary and Respiratory Medicine 1.4k
Countries citing papers authored by Ruth Plummer
This map shows the geographic impact of Ruth Plummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Plummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Plummer more than expected).
Fields of papers citing papers by Ruth Plummer
This network shows the impact of papers produced by Ruth Plummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Plummer. The network helps show where Ruth Plummer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth Plummer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 235 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma Hit paper breakdown → | 2017 | 1143 |
| 2 | 2015 | 355 | |
| 3 | 2011 | 347 | |
| 4 | 2008 | 332 | |
| 5 | 2010 | 313 | |
| 6 | 2008 | 312 | |
| 7 | 2020 | 303 | |
| 8 | Clinical development of new drug–radiotherapy combinations Hit paper breakdown → | 2016 | 284 |
| 9 | 2020 | 212 | |
| 10 | 2007 | 211 | |
| 11 | 2019 | 204 | |
| 12 | 2018 | 201 | |
| 13 | A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer Hit paper breakdown → | 2023 | 185 |
| 14 | 2015 | 177 | |
| 15 | 2013 | 162 | |
| 16 | 2017 | 158 | |
| 17 | 2019 | 152 | |
| 18 | 2019 | 147 | |
| 19 | 2011 | 145 | |
| 20 | 2020 | 144 |
About Ruth Plummer
Ruth Plummer is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 235 papers that have together received 11.1k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (42 papers), DNA Repair Mechanisms (24 papers), Cancer Immunotherapy and Biomarkers (24 papers), Melanoma and MAPK Pathways (21 papers), Colorectal Cancer Treatments and Studies (18 papers), Lung Cancer Treatments and Mutations (14 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Oncology (5.3k citations), Cancer Research (1.1k citations), Molecular Biology (5.1k citations), Immunology (1.1k citations) and Pulmonary and Respiratory Medicine (1.4k citations). Ruth Plummer has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Hilary Calvert, Alan V. Boddy, Timothy Anthony Yap, Mark Ross Middleton, Yvette Drew, Richard H. Wilson, Nicola J. Curtin, Johann Sebastian De Bono, Wolfgang Wick and Michael Weller. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Clinical Cancer Research, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.